Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This was the only WGT bet I owned till just now.
As per AVXL, I just love being part of the group that upsets the FUDsters.
$23, sorry buddy I been here since 2016. Nowhere close to my cost average.
Hopefully, when approved, NWBO`s treatment can help your moms type of cancer.
Otherwise, maybe AVXL can help with that too.
I dont buy the FUDster argument of 2-73 being cancer inducing long term.
I'll take the opposite bet on this!!!
Please continue the exposure!
It`s easier to catch a FUDster than a one legged man!.
Precisely against the rules:
If this is true how come we aren't lower?
Short selling.
Sometimes naked, sometimes borrowed from other large institutions who do not care about short term price moves and make money on the interest or want to set traps for those other hedge funds.
Retail, are little fish swimming in a big ocean.
We are just loud.
Zero chances he drops this piece day after 16 percent gain, by odds alone.
ZEERO
Imagine being so trapped lol
They are shitting their pants boi!!!
cool so much information.
Just a thought:
If you have the goods you ink later, price goes up if the goods are good
If you don't have the goods, you ink it now with contingencies in case of so so data.
Dr.M made it clear it was happening after they release it all.
Been here since 2016.
The rest is bs.
Remember, AVXL share owners are always "disappointed!!"
Especially when they "own" shares!!
Stick to the script dammit!!
Yes, excited about being at the table with potential partners across the world.
Ink dries, partner decision and terms, after FULL analysis is disclosed to market.
Isn't this exciting to you?
Something something north korea, AVXL sucks!
I cant wait to tell you guys about next investors annual meeting!!
Is the only time I snap out of my childish eternal complaints.
Oh cool, how long from now is very soon?
How did you come up with simply wrong, not knowing the time frame?
cool so now what?
They should of had us, in both AD and PD sections
But is a start!
They don't want to admit until is too late.
But we belong in multiple sections.
And that is what bothers.
Always positive about anything Anavex.
So there is a correlation between the share price and interesting posts?
Cool.
If you wanted to avoid a question this is how you do it kids!
Oh yes the period after FDA approval and actually making money sucks.
It all depends on the $ $ from now on if approval was already priced in.
Seems like it was priced in, it went from $61 Jan 21 2022 to $150--155 May double top. So now they have to make money, they are currently valued at $10billion.
I guess you will have to wait for the peer review paper in which is going to published in.
Hope you are still holding to that very small position lol.
Yes then comes the weak attempt to save face lol.
Not if I already owned a crap ton of shares.
Im pretty sure Dr.M is an astute investor like yourself who rather own RISK FREE shares.
He also could of sold all of them, if he wasnt displaying confidence in the future, wouldnt you?
Arent your trading shares already gone?
Or were they repurchased after seeing the data on the 25 Adult Rett patients?
lmao.
Yea Doc, anything on the data on those 25 adults?
Ooops.
So your linked post still doesnt explain the quote below. Where exactly do you retract the CEOs lack of confidence being displayed?
Or the fact that you inferred to him as the cabal.
It's getting very very sad lol
"Sold all exercised shares, wonderful level of confidence displayed by the CEO of Anavex.
At least today's cabal has been identified."
Acaidias partner went up significantly.
So not impressed with the PR?
I think you underestimate the PR.
Pretty darn good PR if even outside the WGT group.
Dont you agree?
We are talking adult Rett here.
Good to know you are still invested on AVXL Doc!! Lol
That sounds like an opinion or wish to me.
Nope not holding anything but a crap load of shares.
In no rush.
No delays on AD data recognized yet.
A delay means you expected the process of analysis to be shorter, or that the company set a date and missed it.
The former is not the reality of the matter just an investors going about his own expectations.
The latter the company has said to be by this year.
So no delay has occurred.
Delayed?
As opposed to what? How do you know is delayed exactly?
Or is it taking the proper amount of time.
Looking forward to your answer.
Back to the ignore list! GL!
That was not what was said. It related to Anavex specifically no mention of other trials were mentioned in the post I responded to.
I brought up other trials.
If that was meant by the poster I stand corrected.
A feature not a bug of speaking in riddles.
Being able to back track
Yea I had to get you off the ignore list to see what Leo was referencing.
Which still doesnt explain how this PR worst case may paint bias data collection from Anavex.
Not sure what you are referring to.
I just fail to see how todays PR may paint a bias on Anavex data collection as claimed.
Good thing we are using the same RSBQ which was recently used by an approved drug.
Even better that the analysis we just made is not based on our trial specifically but on other trials.
The best part is we may be able to compare the results and come up with a better evaluation tool as the study findings conclude.
Not something only Anavex trial`s has to deal with.
Speaking of objective biomarkers, we are trying and leading in the discovery process:
Other Outcome Measures:
Glutamate Plasma Concentration [ Time Frame: 12 weeks ]
Glutamate Plasma Concentration
GABA Plasma Concentration [ Time Frame: 12 weeks ]
GABA Plasma Concentration
But ALL trials using RSBQ and CGI, including the one recently approved by FDA deal with the inherited bias.
So how can Anavex lend itself for bias criticism again?